NCT00013598
- Conditions
- Body Weight, Carotid Intimal Medial Thickness 1, Diabetes Mellitus, +19 more
- Locations
-
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States
Clinical trial condition
Nonalcoholic Steatohepatitis
Explore clinical trials studying Nonalcoholic Steatohepatitis. Study availability and eligibility vary by location and protocol.
95 public trials
6 recruiting studies
Nonalcoholic Steatohepatitis trial results
Active, Not Recruiting
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes
NCT04595474
- Conditions
- Autoimmune Diseases, Cirrhosis, Liver, Diabetes Mellitus, +18 more
- Locations
-
- Joslin Diabetes Center Boston, Massachusetts, United States
Active, Not Recruiting
A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)
NCT06465186
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +6 more
- Locations
-
- The Institute for Liver Health II dba Arizona Clinical Trial-The Institute for Liver Health ( Site 0149) Chandler, Arizona, United States
- Arizona Clinical Trials ( Site 0158) Flagstaff, Arizona, United States
- The Institute for Liver Health II dba Arizona Liver Health - Peoria ( Site 0120) Peoria, Arizona, United States
- The Institute for Liver Health II dba Arizona Liver Health-Tucson ( Site 0111) Tucson, Arizona, United States
Active, Not Recruiting
Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study
NCT04550481
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
- Cedars Sinai Medical Center Los Angeles, California, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
- Mount Sinai Hospital New York, United States
- Duke University Medical Center Durham, North Carolina, United States
Active, Not Recruiting
Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis
NCT05979779
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +3 more
- Locations
-
- ProSciento CRU Chula Vista, California, United States
- Velocity Clinical Research Los Angeles, California, United States
- Catalina Research Institute Montclair, California, United States
- Northern California Research Center Sacramento, California, United States